Vaccines for the Prevention of Melioidosis and Glanders

Vaccines for the Prevention of Melioidosis and Glanders Curr Trop Med Rep (2017) 4:136–145 DOI 10.1007/s40475-017-0121-7 MELIOIDOSIS AND TROPICAL BACTERIOLOGY (A TORRES, SECTION EDITOR) 1 1 Monica M. Johnson & Kristy M. Ainslie Published online: 14 July 2017 Springer International Publishing AG 2017 Abstract mallei, the causative agent of glanders, are aerobic, gram-neg- Purpose of Review Burkholderia pseudomallei’sand ative, motile bacilli classified by the US Centers for Disease Burkholderia mallei’s high rate of infectivity, limited treat- Control and Prevention (CDC) as tier 1 select agents due to ment options, and potential use as biological warfare agents high virulence when inhaled and potential to cause large-scale underscore the need for development of effective vaccines illness if disseminated. Additionally, Burkholderia spp. against these bacteria. Research efforts focused on vaccines have resistance to a wide range of antibiotics, including against these bacteria are in preclinical stages, with no ap- penicillin [2, 3], which adds additional concern surround- proved formulations currently on the market. ing the bacteria. Research efforts over the last decade Recent Findings Several live attenuated and subunit vaccine have evaluated prophylactic and therapeutic treatment formulations have been evaluated in animal studies, with no options to combat these emerging infectious diseases; reports of significant long-term survival after lethal challenge. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Tropical Medicine Reports Springer Journals

Vaccines for the Prevention of Melioidosis and Glanders

Loading next page...
 
/lp/springer_journal/vaccines-for-the-prevention-of-melioidosis-and-glanders-h4Rv4mSNW9
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG
Subject
Medicine & Public Health; Tropical Medicine; Parasitology; Behavioral Sciences; Infectious Diseases
eISSN
2196-3045
D.O.I.
10.1007/s40475-017-0121-7
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial